Longview Innovation
Overview
Longview Innovation is a venture investment firm that forms and grows early-stage companies by commercializing academic and national laboratory intellectual property in the medtech, materials, synthetic biology, and energy sectors.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Exyn Technologies | Jul 2019 | Series A | Co-investor |
| Azuri Technologies | Jun 2019 | Growth Equity | Co-investor |
| CareAlign | Oct 2019 | Pre Seed | Co-investor |
| Aptatek BioSciences, Inc. | Sep 2026 | Early Funding | Lead |
| Innervace | Sep 2022 | Series A | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Longview Innovation based?
Longview Innovation is headquartered in Wilmington, Delaware, United States.
When was Longview Innovation founded?
Longview Innovation was founded in 2013.
How many portfolio companies does Longview Innovation have?
Longview Innovation has 9 portfolio companies in Caplight's dataset.
What are some companies in Longview Innovation's portfolio?
Portfolio companies visible on Caplight include Exyn Technologies, Azuri Technologies, CareAlign, Aptatek BioSciences, Inc., Innervace.
What was Longview Innovation's most recent investment shown here?
Longview Innovation's most recent investment in this portfolio sample was in Aptatek BioSciences, Inc. in 2026.
What sectors does Longview Innovation focus on?
Longview Innovation focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Healthcare & Life Sciences, Energy & Sustainability, Healthcare & Life Sciences, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech, Enterprise Software, AI, Data & Cloud Infrastructure, Enterprise Software, Enterprise Software, FinTech, Frontier & Industrial Tech.
What company stages does Longview Innovation focus on?
Stage focus information for Longview Innovation is not publicly available.